Computational investigation of marine bioactive compounds reveals frigocyclinone as a potent inhibitor of Kaposi’s Sarcoma Associated Herpesvirus (KSHV) targets-Reference-Cited by-同舟云学术

Computational investigation of marine bioactive compounds reveals frigocyclinone as a potent inhibitor of Kaposi’s Sarcoma Associated Herpesvirus (KSHV) targets

Published:2019-08-21 Issue:3 Volume:12 Page:1289-1302
ISSN:2456-2610
Container-title:Biomedical & Pharmacology Journal
language:en
Short-container-title:Biomed. Pharmacol. J.

Author:

Ponnusamy Nirmaladevi¹,Odumpatta Rajasree¹,Damodharan Pavithra¹,Arumugam Mohanapriya¹

Affiliation:

1. Department of Biotechnology, Vellore Institute of Technology, Vellore, 632014-India.

Abstract

In the present study, in silico analysis was employed to identify the action of marine bioactive compounds against KSHV targets. Virulence factor analysis of KSHV from literature review, three proteins LANA1, vIRF3/LANA2 and PF-8 were identified as putative drug targets. The quality of protein structures play a significant role in the experimental structure validation and prediction, where the predicted structures may contain considerable errors was checked by SAVES v5.0 servers. By virtual screening four potential bioactive compounds Ascorbic acid, Salicylihalamide A, Salicylihalamide B and Frigocyclinone were predicted. One of the potential compounds of Frigocyclinone has acting against KSHV proteins. Hence, determined as the good lead molecule against KSHV. Molecular dynamic simulation studies revealed the stability of LANA1- Frigocyclinone complex and it could be a futuristic perspective chemical compound for Kaposi’s sarcoma.

Publisher

Oriental Scientific Publishing Company

Subject

Pharmacology

Reference96 articles.

1. Beral V, Peterman T. A, Berkelman R. L and Jaffe H. W. Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection? Lancet., 1990; 335(8682): 123-128.

2. Host K. M, Jacobs S. R, West J. A, Zhang Z, Costantini L. M, Stopford C. M, Dittmer D. P and Damania B. Kaposi’s Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes. Imperiale MJ. ed. mBio., 2017; 8(5): e00917.

3. Sharma-Walia N, Paul A. G, Bottero V, Sadagopan S, Veettil M. V, Kerur N and Chandran B. Kaposi’s Sarcoma Associated Herpes Virus (KSHV) Induced COX-2: A Key Factor in Latency, Inflammation, Angiogenesis, Cell Survival and Invasion. Nelson JA, ed. PLoS Pathogens., 2010; 6(2): e1000777.

4. Dourmishev L. A, Dourmishev A. L, Palmeri D, Schwartz R. A and Lukac D. M. Molecular genetics of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol. Biol. Rev., 2003; 67(2): 175-212.

5. Stürzl M, Zietz C, Monini P and Ensoli B. Human herpesvirus-8 and Kaposi’s sarcoma: relationship with the multistep concept of tumorigenesis. Adv. Cancer Res., 2001; 81: 125-159.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unleashing the Potential of Microbial Natural Products in Drug Discovery: Focusing on Streptomyces as Antimicrobials Goldmine;Current Topics in Medicinal Chemistry;2021-12-01

2. Natural Products and Their Derivatives against Human Herpesvirus Infection;Molecules;2021-10-18